Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Dry JR"'
Autor:
Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, Nag S, da Silva EM, Yildirim SY, Li Q, O'Connell E, Patel P, Will M, Fushimi A, Benitez M, Bradic M, Fan L, Nakshatri H, Sudhan DR, Denz CR, Reis-Filho JS, Goel S, Koff A, Weigelt B, Khan QJ, Razavi P, Chandarlapaty S
Publikováno v:
Cancer cell [Cancer Cell] 2024 Nov 11; Vol. 42 (11), pp. 1983.
Autor:
Kudo R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Department of Surgery, The Jikei University School of Medicine, Tokyo 1058461, Japan., Safonov A; Breast Medicine Service, Department of Medicine, MSK, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA., Jones C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA., Moiso E; Department of Medicine, MSK, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, MSK, New York, NY 10065, USA., Dry JR; Tempus AI, Boston, MA 02110, USA., Shao H; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA., Nag S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA., da Silva EM; Department of Pathology and Laboratory Medicine, MSK, New York, NY 10065, USA., Yildirim SY; Department of Pathology and Laboratory Medicine, MSK, New York, NY 10065, USA., Li Q; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA., O'Connell E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA., Patel P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA., Will M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSK, New York, NY 10065, USA; Clinical Genetics Service, Department of Medicine, MSK, New York, NY 10065, USA., Fushimi A; Department of Surgery, The Jikei University School of Medicine, Tokyo 1058461, Japan., Benitez M; Program in Molecular Biology, Sloan Kettering Institute, MSK, New York, NY 10065, USA., Bradic M; Program in Molecular Biology, Sloan Kettering Institute, MSK, New York, NY 10065, USA., Fan L; Helen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10021, USA., Nakshatri H; Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Sudhan DR; Oncology R&D, AstraZeneca, Waltham, MA 02451, USA., Denz CR; Oncology R&D, AstraZeneca, Waltham, MA 02451, USA., Huerga Sanchez I; Tempus AI, Boston, MA 02110, USA., Reis-Filho JS; Department of Pathology and Laboratory Medicine, MSK, New York, NY 10065, USA., Goel S; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3000, Australia., Koff A; Program in Molecular Biology, Sloan Kettering Institute, MSK, New York, NY 10065, USA., Weigelt B; Department of Pathology and Laboratory Medicine, MSK, New York, NY 10065, USA., Khan QJ; Division of Medical Oncology, The University of Kansas Medical Center, Kansas City, KS 66160, USA., Razavi P; Breast Medicine Service, Department of Medicine, MSK, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: razavip@mskcc.org., Chandarlapaty S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSK, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: chandars@mskcc.org.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Nov 11; Vol. 42 (11), pp. 1919-1935.e9. Date of Electronic Publication: 2024 Oct 10.
Autor:
Papp O; Turbine Simulated Cell Technologies, Budapest, Hungary., Jordán V; Turbine Simulated Cell Technologies, Budapest, Hungary., Hetey S; Turbine Simulated Cell Technologies, Budapest, Hungary., Balázs R; Turbine Simulated Cell Technologies, Budapest, Hungary., Kaszás V; Turbine Simulated Cell Technologies, Budapest, Hungary., Bartha Á; Turbine Simulated Cell Technologies, Budapest, Hungary., Ordasi NN; Turbine Simulated Cell Technologies, Budapest, Hungary., Kamp S; Turbine Simulated Cell Technologies, Budapest, Hungary., Farkas B; Turbine Simulated Cell Technologies, Budapest, Hungary., Mettetal J; Oncology Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, USA., Dry JR; Early Data Science, Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA., Young D; Search and Evaluation, Oncology R&D, AstraZeneca, Cambridge, UK., Sidders B; Early Data Science, Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK., Bulusu KC; Early Data Science, Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK., Veres DV; Turbine Simulated Cell Technologies, Budapest, Hungary. daniel.veres@turbine.ai.
Publikováno v:
NPJ systems biology and applications [NPJ Syst Biol Appl] 2024 Aug 08; Vol. 10 (1), pp. 83. Date of Electronic Publication: 2024 Aug 08.
Autor:
Papp O; Turbine Simulated Cell Technologies, Budapest, Hungary., Jordán V; Turbine Simulated Cell Technologies, Budapest, Hungary., Hetey S; Turbine Simulated Cell Technologies, Budapest, Hungary., Balázs R; Turbine Simulated Cell Technologies, Budapest, Hungary., Kaszás V; Turbine Simulated Cell Technologies, Budapest, Hungary., Bartha Á; Turbine Simulated Cell Technologies, Budapest, Hungary., Ordasi NN; Turbine Simulated Cell Technologies, Budapest, Hungary., Kamp S; Turbine Simulated Cell Technologies, Budapest, Hungary., Farkas B; Turbine Simulated Cell Technologies, Budapest, Hungary., Mettetal J; Oncology Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, USA., Dry JR; Early Data Science, Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA., Young D; Search and Evaluation, Oncology R&D, AstraZeneca, Cambridge, UK., Sidders B; Early Data Science, Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK., Bulusu KC; Early Data Science, Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK., Veres DV; Turbine Simulated Cell Technologies, Budapest, Hungary. daniel.veres@turbine.ai.
Publikováno v:
NPJ systems biology and applications [NPJ Syst Biol Appl] 2024 Jun 21; Vol. 10 (1), pp. 68. Date of Electronic Publication: 2024 Jun 21.
Autor:
Hobor S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK., Skrzypski M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.; Department of Oncology and Radiotherapy, Medical University of Gdańsk, ul. Mariana Smoluchowskiego 17, 80-214, Gdańsk, Poland., Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK., Bakker B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Markovets A; Oncology Data Science, Oncology R&D, AstraZeneca, Boston, MA, USA., Dry JR; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Brown AP; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., van der Aart J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., van den Bos H; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Spierings D; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Oukrif D; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK., Novelli M; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK., Chakrabarti T; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Rabinowitz AH; Furlong Laboratory, EMBL Meyerhofstraße 1, 69117, Heidelberg, Germany., Ait Hassou L; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Litière S; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK., Kerr DL; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Tan L; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Kelly G; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Renshaw MJ; Advanced Light Microscopy, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Venkatesan S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Wu W; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Chmielecki J; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett C; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Chew SK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK., Blakely CM; Department of Medicine, University of California, San Francisco, CA, 94158, USA., de Bruin EC; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Vousden KH; p53 and Metabolism Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Bivona TG; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, USA., Hynds RE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. n.kanu@ucl.ac.uk., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. s.zaccaria@ucl.ac.uk.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK. s.zaccaria@ucl.ac.uk., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Eva.Gronroos@crick.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Charles.Swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. Charles.Swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK. Charles.Swanton@crick.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 13; Vol. 15 (1), pp. 4871. Date of Electronic Publication: 2024 Jun 13.
Autor:
Hernandez KM; Department of Medicine, University of Chicago, Chicago, Illinois; Center for Translational Data Science, University of Chicago, Chicago, Illinois., Bramlett KS; Thermo Fisher Scientific, Austin, Texas., Agius P; Tempus, Chicago, Illinois., Baden J; Bristol Myers Squibb, Newton, New Jersey., Cao R; Thermo Fisher Scientific, Austin, Texas., Clement O; SeraCare Life Sciences Inc., Milford, Massachusetts., Corner AS; Digital Biology Group, Bio-Rad Laboratories Inc., Pleasanton, California., Craft J; Sysmex Inostics, Baltimore, Maryland., Dean DA 2nd; Seven Bridges, Charlestown, Massachusetts., Dry JR; Tempus, Chicago, Illinois., Grigaityte K; Tempus, Chicago, Illinois., Grossman RL; Department of Medicine, University of Chicago, Chicago, Illinois; Open Commons Consortium, Chicago, Illinois; Pfizer, San Diego, California., Hicks J; Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA., Higa N; Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA., Holzer TR; Eli Lilly and Company, Indianapolis, Indiana., Jensen J; Fluxion Biosciences, San Francisco, California., Johann DJ; Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Katz S; Illumina, San Diego, California., Kolatkar A; Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA., Keynton JL; Horizon Discovery, Cambridge, United Kingdom., Lee JSH; Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA; Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, California., Maar D; Digital Biology Group, Bio-Rad Laboratories Inc., Pleasanton, California., Martini JF; Pfizer, San Diego, California., Meyer CG; Center for Translational Data Science, University of Chicago, Chicago, Illinois., Roberts PC; Pfizer, San Diego, California., Ryder M; Sysmex Inostics, Baltimore, Maryland., Salvatore L; Open Commons Consortium, Chicago, Illinois., Schageman JJ; Thermo Fisher Scientific, Austin, Texas., Somiari S; Windber Research Institute, Windber, Pennsylvania., Stetson D; AstraZeneca, Waltham, Massachusetts., Stern M; Bristol Myers Squibb, Newton, New Jersey., Xu L; Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA., Leiman LC; BLOODPAC, Chicago, Illinois. Electronic address: lauren@bloodpac.org.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Mar; Vol. 25 (3), pp. 143-155.
Autor:
Criscione SW; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA. Steven.Criscione@astrazeneca.com., Martin MJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Oien DB; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Gorthi A; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Department of Cell Systems & Anatomy, Greehey Children's Cancer Research Institute, University of Texas at Health San Antonio, San Antonio, TX, USA., Miragaia RJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Zhang J; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Chen H; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Karl DL; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Mendler K; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Markovets A; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Gagrica S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Delpuech O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Dry JR; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Grondine M; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Hattersley MM; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Urosevic J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Floc'h N; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Drew L; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Yao Y; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA. yiyao1147@gmail.com., Smith PD; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK. Paul.D.Smith@astrazeneca.com.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Dec 27; Vol. 6 (1), pp. 95. Date of Electronic Publication: 2022 Dec 27.
Autor:
Leibowitz BD; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Dougherty BV; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Bell JSK; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Kapilivsky J; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Michuda J; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Sedgewick AJ; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Munson WA; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Chandra TA; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Dry JR; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Beaubier N; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Igartua C; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Taxter T; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States. tim@tempus.com.
Publikováno v:
BMC cancer [BMC Cancer] 2022 May 28; Vol. 22 (1), pp. 587. Date of Electronic Publication: 2022 May 28.
Autor:
Ahmed T; Tempus Labs Inc., Chicago, IL 60654, USA., Carty MA; Tempus Labs Inc., Chicago, IL 60654, USA., Wenric S; Tempus Labs Inc., Chicago, IL 60654, USA., Dry JR; Tempus Labs Inc., Chicago, IL 60654, USA., Salahudeen AA; Tempus Labs Inc., Chicago, IL 60654, USA., Khan AA; Tempus Labs Inc., Chicago, IL 60654, USA., Lefkofsky E; Tempus Labs Inc., Chicago, IL 60654, USA., Stumpe MC; Tempus Labs Inc., Chicago, IL 60654, USA., Pelossof R; Tempus Labs Inc., Chicago, IL 60654, USA.
Publikováno v:
Briefings in bioinformatics [Brief Bioinform] 2022 May 13; Vol. 23 (3).
Autor:
Gogleva A; Biological Insight Knowledge Graph (BIKG), AI Engineering, R&D IT, AstraZeneca, Cambridge, UK., Polychronopoulos D; Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Pfeifer M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Poroshin V; NLP Lab, Enterprise AI Services, IGNITE, AstraZeneca, Cambridge, UK., Ughetto M; Biological Insight Knowledge Graph (BIKG), AI Engineering, R&D IT, AstraZeneca, Gothenburg, Sweden., Martin MJ; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Thorpe H; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Bornot A; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Smith PD; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Sidders B; Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Dry JR; Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, USA., Ahdesmäki M; Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., McDermott U; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Papa E; Biological Insight Knowledge Graph (BIKG), AI Engineering, R&D IT, AstraZeneca, Cambridge, UK. elipapa@alum.mit.edu., Bulusu KC; Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK. krishna.bulusu@astrazeneca.com.
Publikováno v:
Nature communications [Nat Commun] 2022 Mar 29; Vol. 13 (1), pp. 1667. Date of Electronic Publication: 2022 Mar 29.